Ramiro Ribeiro After six years as head of clinical development at Apellis Pharmaceuticals, Ramiro Ribeiro is joining EyePoint Pharmaceuticals as...
Great Expectations
What will drive markets in 2020?
3 things to know about emerging market debt
Three strategies to limit losses
The dreaded month-long downtrend